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Abstract
Background: Gene dosage change is a mild perturbation that is a valuable tool for pathway reconstruction in
Drosophila. While it is often assumed that reducing gene dose by half leads to two-fold less expression, there is
partial autosomal dosage compensation in Drosophila, which may be mediated by feedback or buffering in
expression networks.
Results: We profiled expression in engineered flies where gene dose was reduced from two to one. While
expression of most one-dose genes was reduced, the gene-specific dose responses were heterogeneous.
Expression of two-dose genes that are first-degree neighbors of one-dose genes in novel network models also
changed and the directionality of change depended on the response of one-dose genes.
Conclusions: Our data indicate that expression perturbation propagates in network space. Autosomal
compensation, or the lack thereof, is a gene-specific response, largely mediated by interactions with the rest of the
transcriptome.
Background
Systematic evaluation of gene dose in segmental aneu-
ploids shows that dose changes in the majority of the
Drosophila genome are compatible with life [1,2], but if
there are enough changes in dose, regardless of the par-
ticular genes, viability is greatly reduced [2]. This sug-
gests that gene dose changes have small additive effects
on viability in Drosophila, which may be analogous to
the situation in humans, where small regions of segmen-
tal aneuploidy are associated with subtle adult phenotyes
(for example, disease) and large departures from ploidy
result in fetal death [3-5]. The small effect of gene dose,
and the significant additive effects when there are
enough of these changes, suggest that large departures
from gene balance collapse genetic networks.
Understanding the effect of copy number on gene
expression is a prerequisite for systematic study of gene
dose as a network attribute.
While there are clear dose effects on viability in seg-
mental aneuploids [2] and in dominant genetic interac-
tions in Drosophila (for example, [6]), the effect of copy
number may be less than implied by the gene dose per
se. One-dose genes in flies heterozygous for deficiencies
(deletions removing multiple loci) show average expres-
sion values less than two-fold reduced [7-9]. Expression
also shows a sublinear relationship to gene dose in
highly aneuploid Drosophila tissue culture cells [10]. In
whole Drosophila showing aneuploidy, some genes in
trisomic regions show compensation, while others do
not, at both the transcript and protein levels [11,12]. All
these data indicate that gene dose responses are not
always a simple reflection of copy number. We do not
have well-developed models for the important relation-
ship between gene dose and expression in Drosophila,
but there are at least two general mechanisms that we
test here.
One model for autosomal dosage compensation sug-
gests that deletions in autosomes are recognized as
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aneuploid segments and partially compensated in a
fixed-fold manner independent of the specific gene.
There is strong evidence that extensive chromosome-
level aneuploidy results in a characteristic stress
response in both yeast and mouse cells [13]. One can
imagine, therefore, that a compensatory response to
aneuploidy would be advantageous for cells (although
perhaps not organisms, which might rather purge aneu-
ploid cells). There is good agreement in average autoso-
mal dosage compensation levels reported in Drosophila
[8,9,14], which would be expected if a global aneuploid
recognition/correction system existed. Indeed, there are
at least two such systems. Wild-type Drosophila are
diploid for two major autosomes, a dot autosome (chro-
mosome 4), and have either one (males) or two × chro-
mosomes (females). Much of the work on the gene
dosage in Drosophila has focused on the × chromosome,
where a chromatin-remodeling machine (the male-speci-
fic lethal (MSL) complex) recognizes and decorates the
× to increase gene expression in males [15] by promot-
ing transcriptional elongation [16]. However, the small
fourth chromosome is also recognized by a chromatin
remodeling machine (Painting of fourth, Pof) to increase
gene expression [7]. An analogous global mechanism
could partially and uniformly compensate for segmental
aneuploid regions that arise by mutation on the remain-
ing two major autosomes. If such a system exists, then
expression of a common set of genes encoding this
machinery would be expected to increase in segmental
aneuploid Drosophila, regardless of the particular loca-
tion of the aneuploid segment. Even in the case of these
remodeling systems the relationship between dose and
expression is not simple. There is an × chromosome-
specific compensation system in Drosophila that acts in
the soma during embryogenesis, but not in the germline.
Some genes on the × chromosome in males show
dosage compensation prior to the activation of the prin-
cipal dosage compensation system in the soma [17], and
× chromosome genes in the mitotic male germline,
where the somatic dosage compensation system does
not operate, are tightly dosage compensated [9,18].
There are other possible dosage compensation mechan-
isms. A second model suggests that feedback mechanisms
[19] and the dampening of dose effects due to the kinetic
properties of flux through networks [20] result in partial
dosage compensation depending on the specific gene with
a dose change. This network model is supported by the
fact that gene dose manipulation is a powerful pathway
reconstruction tool in Drosophila, where deficiencies
result in a sensitized genetic background for discovering
new pathway members [21,22]. These studies strongly sug-
gest that gene dose reductions for individual loci result in
reduced gene activity and a subtle propagation of pertur-
bations into regulatory networks. In classical genetic
terms, this suggests that many genes may have subliminal
haplo-insufficient properties, resulting in synthetic or
background-dependent phenotypes only when nearby
gene activities in the pathway are suboptimal. This gene-
specific response hypothesis makes three clear predictions:
1) genes should show individual characteristic expression
responses to reduction in dose; 2) these responses should
occur in the context of the gene expression network in
which they are embedded; and 3) expression deviations
from genes with reduced dose should propagate into the
expression network.
Our work on gene expression in a series of Drosophila
deficiencies analyzed in the context of different network
models indicates that gene interactions play a large role
in autosomal dose effects and dosage compensation. We
suggest that studies in model organisms, with a more
controlled genetic background and environment, will
help us parse out the complexities of gene dose effects
and interactions among large sets of genes that make
small contributions to overt morphological or physiolo-
gical phenotypes in development and disease.
Results
Drosophila lines with reduced gene dose
We took advantage of the Drosophila model system by
measuring genome-wide mRNA expression in engi-
neered autosomal deficiency lines (Df/+) from the Eur-
opean Drosophila deletion collection (DrosDel) project
[22,23]. The DrosDel collection offered a key experi-
mental advantage, as all strains are from the same origi-
nal stock, minimizing genetic background outside of the
engineered deletion. We selected 21 DrosDel deficiency
lines from chromosome arm 2L to survey mRNA
responses to gene dose in adult flies (Figure 1). The test
set allowed us to look at one-dose genes in five regions
with multiple deficiencies, so that we could explore the
question of whether compensation is a property of indi-
vidual genes or particular deficiencies. The Dfs removed
a variable number of genes and were scattered along the
length of the chromosome arm.
While the engineered deletions we used have mole-
cularly defined breakpoints, spontaneous rearrange-
ments do occur. Additionally, Drosophila has many
tissues with variably endoreplicated genomes [24],
which might provide a corrective amplification. To
directly assess gene dose in the Df/+ flies, we per-
formed DNA-sequencing (DNA-Seq, average sequen-
cing depth 3.2×) on adult females and males of all 21
lines and the parental line. We aligned genome-wide
to confirm genotypes (Table 1; Additional file 1), to
test for selective endoreplication, and to detect any
novel structural rearrangements. While we did observe
known selective endoreplication events at the chorion
loci in females, we found no evidence to support the
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idea that selective amplification was part of the dosage
compensation response. DNA-Seq coverage of wild-
type autosomes was two-fold higher (standard devia-
tion (SD) = 0.2) than in the engineered deletion
regions, indicating that all Dfs reduce gene dose by
half. In one case (Df(2L)ED478), we found an addi-
tional uncharacterized deficiency, which we named Df
(2L)EDHsp60c, but otherwise we detected no overt
novel rearrangements elsewhere in the genomes, indi-
cating that dose had not deviated in the time following
creation of the original engineered deletions.
We performed expression experiments on both
females and males because, in a network model for dose
effects and compensation, the responses to gene dose
should differ depending on expression context. There is
a long history of expression profiling between the sexes
that has clearly shown that females and males have sub-
stantially different expression networks, due in large
measure to the gonads and particularly the germ cells
[9,25-28]. Because of the large gonad size relative to the
rest of the body, these sex-biased expression profiles are
quite evident in whole adults. While there are advan-
tages to examining expression networks by cell type, tis-
sue or organ, we were concerned about introducing
dissection as a variable in the experiments; therefore, we
performed all work on whole females and males.
Expression of one-dose genes in Df/+ flies
To determine the overall pattern of dose responses, we
pooled expression measurements for all 478 one-dose
genes in the entire set of deficiencies and compared
expression to a wild-type reference built from the same set
of experiments (Additional file 2). We then used resam-
pling methods to compare the expression of similar num-
bers of one-dose and two-dose genes. Because expression
of genes physically linked on chromosomes are often corre-
lated [29], we sampled contiguous blocks of two-dose
genes along the genome to obviate any effects due to the
non-random arrangement of genes. As expected, we
observed lower expression from the one-dose genes (Figure
2a,b). Females and males showed similar overall responses
to this copy number change with a mean 1.6-fold reduction
in expression. This was less expression change than the
two-fold reduction predicted if expression strictly followed
gene dose, and is in line with previous studies [7].
The distribution of responses around means could be
due to biological and technical noise layered over a 1.6-
fold partial-compensation system that the cellular
machinery applied uniformly to all one-copy genes, or
gene-specific responses due to feedback. If there were a
general fixed-fold aneuploid response system, then error
and noise should be normally distributed around the














































Figure 1 Lines used. Positional map of the start and stop positions (black bars) for deficiencies (Df(2L)EDs, on left) profiled along chromosome
2L (gray bars) and the number of coding genes (on right) removed in full or part. Each line had a single deficiency region with the exception of
one line (asterisk) containing Df(2L)ED478 as well as the de novo Df(2L)Hsp60c. Overlapping deficient regions are shown (dashed lines, open bars).
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This was not the case. Mean centered distributions
showed extended tails and skewing towards better
dosage compensation when compared to the expression
distributions of two-dose genes (Figure 2c,d). The distri-
bution of one-dose genes was not normal (P < 0.01, Jar-
que-Bera test), and the differences in distribution shape
Table 1 DNA-Seq measurements for aneuploid segments
Deficiency First missing base Last missing base Measured in RPM in Df region RPM in WT Fold difference
Df(2L)ED2809/+ 67365 72671 Female 29.5 54.3 1.84
Df(2L)ED2809/+ 67365 72671 Male 27.9 60.3 2.16
Df(2L)ED62/+ 480873 826788 Female 1,371.5 2,912.8 2.12
Df(2L)ED62/+ 480873 826788 Male 1,366.1 3,313.8 2.43
Df(2L)ED80/+ 568095 850645 Female 1,168.28 2,373.4 2.03
Df(2L)ED80/+ 568095 850645 Male 1,253.1 2,691.5 2.14
Df(2L)ED87/+ 568095 852827 Female 1,103.5 2,390.5 2.17
Df(2L)ED87/+ 568095 852827 Male 1,177.3 2,711.5 2.30
Df(2L)EDHsp60c/+ 5564618 5809650 Female 1,060.5 2,151.0 2.03
Df(2L)EDHsp60c/+ 5564618 5809650 Male 1,170.1 2,362.2 2.02
Df(2L)ED280/+ 5801930 5907456 Female 447.8 922.5 2.06
Df(2L)ED280/+ 5801930 5907456 Male 509.2 970.4 1.92
Df(2L)ED292/+ 5801930 5981009 Female 744.8 1,510.1 2.03
Df(2L)ED292/+ 5801930 5981009 Male 804.1 1,648.5 2.05
Df(2L)ED385/+ 5980272 6465772 Female 1,801.7 3,841.6 2.13
Df(2L)ED385/+ 5980272 6465772 Male 2,130.8 4,350.7 2.04
Df(2L)ED7007/+ 6709099 6963808 Female 1,989.6 2,107.4 1.06
Df(2L)ED7007/+ 6709099 6963808 Male 1,401.4 2,308.7 1.65
Df(2L)ED489/+ 7204186 7576637 Female 1,692.6 3,338.0 1.97
Df(2L)ED489/+ 7204186 7576637 Male 1,803.2 3,485.6 1.93
Df(2L)ED499/+ 7423765 7800182 Female 1,727.3 3,337.2 1.93
Df(2L)ED499/+ 7423765 7800182 Male 1,844.5 3,514.0 1.91
Df(2L)ED475/+ 7423915 7576637 Female 700.2 1,428.4 2.04
Df(2L)ED475/+ 7423915 7576637 Male 786.9 1,474.1 1.87
Df(2L)ED478/+ 7437442 7576637 Female 581.2 1,309.2 2.26
Df(2L)ED478/+ 7437442 7576637 Male 628.7 1,348.3 2.14
Df(2L)ED623/+ 8403564 8700124 Female 1,335.1 2,531.3 1.90
Df(2L)ED623/+ 8403564 8700124 Male 1,504.1 2,718.2 1.81
Df(2L)ED695/+ 9699225 9918192 Female 929.1 1,858.3 2.00
Df(2L)ED695/+ 9699225 9918192 Male 1,009.2 2,041.9 2.02
Df(2L)ED775/+ 12010010 12975028 Female 4,424.3 7,821.9 1.77
Df(2L)ED775/+ 12010010 12975028 Male 4,758.8 8,352.9 1.76
Df(2L)ED776/+ 12434538 12975028 Female 2,086.6 4,337.0 2.08
Df(2L)ED776/+ 12434538 12975028 Male 2,347.3 4,638.7 1.98
Df(2L)ED777/+ 12484452 12975028 Female 1,997.0 3,910.5 1.96
Df(2L)ED777/+ 12484452 12975028 Male 2,387.6 4,182.3 1.75
Df(2L)ED793/+ 13934848 14689337 Female 3,324.0 6,563.4 1.97
Df(2L)ED793/+ 13934848 14689337 Male 3,619.5 7,125.3 1.97
Df(2L)ED800/+ 14490575 15332688 Female 3,750.7 6,968.0 1.86
Df(2L)ED800/+ 14490575 15332688 Male 4,032.9 7,456.4 1.85
Df(2L)ED1231/+ 19158440 19464056 Female 1,266.4 2,533.5 2.00
Df(2L)ED1231/+ 19158440 19464056 Male 1,362.8 2,789.8 2.05
Df(2L)ED1305/+ 20085397 20382385 Female 932.4 1,831.8 1.96
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Figure 2 Expression of one-dose genes. (a,b) Histograms of expression values for one-dose genes and the same number of two-dose genes
generated by resampling expression values (2,000×). This corrects for the large sample size differences between these two dose classes.
Resampling of two-dose genes was restricted to contiguous regions corresponding in gene content to the extent of gene deletion in Dfs to
control for nonrandom expression values resulting from co-regulation of physically linked genes. The expected value for non-compensation is
shown (dotted line). Mean expression differences are indicated above each distribution. (c,d) Mean centered distributions of the graphs in (a,b).
(e) Prevalence of dosage compensation classes (see Materials and methods). (f) Notched boxplots of variance (fold-difference2) calculated for
sampled (2,000×) one-dose genes due to different Dfs compared to variance of the same genes in a two-dose state. Medians (bar), 95%
confidence intervals (notch), 25 to 75 percentiles (box), and 1.5 × interquartile range (whiskers) are shown. Wt, wild type.
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of one-dose and two-dose genes was significant (P <
0.01, Kolmogorov-Smirnov test), indicating that the
spread in the expression values of one-dose genes was
not due to measurement error or biological noise in the
system. The response to reduced dose was heteroge-
neous in nature.
For analyses we will present later in the manuscript, it
was useful to classify the dosage compensation
responses. Genes within the bounds of models for fully
or non-compensated were classified as such. We classi-
fied genes failing both models (P < 0.05) as anti-, par-
tially or over-compensated based on the position
relative to the two models (see Materials and methods).
Non-compensation and partial compensation classes
accounted for the most genes, but we also observed
skewing toward better compensation following classifica-
tion (Figure 2e). These classifications also show the het-
erogeneous nature of the dose response, and suggest
that dosage compensation responses were gene-specific.
To more directly test for a gene-specific response, we
asked if the dosage compensation response of a given
one-dose gene was significantly different when tested in
the context of different deficiencies, which all uncover
the same one-dose gene. This test had the added advan-
tage of exploring the idea that there are deletion-specific
compensation levels. Such effects might be mediated by
changes in the complex three-dimensional structure of
the nucleus arising from deletions and juxtaposition of
breakpoints. We observed no significant differences in
expression when the same one-dose gene was measured
in the context of different deficiencies. Additionally, we
analyzed variance in expression among one-dose genes
compared to those same loci when present in two doses.
There was no significant change in expression variance
due to gene dose (Figure 2f). We also found no signifi-
cant correlation between Df extent (amount of DNA or
number of contiguous genes removed), or position
along the chromosome, and compensation class (Addi-
tional file 3). These data indicate that the one-dose
response was gene-specific.
We found a clear correlation (P < 0.01) between
expression level and compensation state. No compensa-
tion was more prevalent at high expression levels, while
compensation was more prevalent at lower expression
levels (Figure 3a,b). However, it is important to note
that we observed a range of reproducible responses to
dose at all expression levels. One has to be particularly
careful with assessing compensation levels in expression
experiments, as technical noise at low expression levels
can falsely suggest compensation. We were rigorous
with low-level cutoff values (>2 SD above background in
all 21 lines; see Materials and methods), strongly sug-
gesting that better observed compensation at low
expression levels was not due to spurious ratiometric
values due to noise. Importantly, we found support for
the array data by Illumina and SOLiD RNA-Seq on
three of the deficiency lines, suggesting that genes with
lower expression levels were indeed more fully compen-
sated (Figure 3c,d). Furthermore, we used sets of 96
control RNAs of known abundance as external RNA
spike-ins produced by the External RNA Control Con-
sortium (ERCC) [30] to calibrate expression ratios over
a range of expression values in these experiments. Data
from the SOLiD platform showed linearity between the
observed and expected abundances and lack of data
compression (Figure 3e). We have previously demon-
strated the linearity of Illumina RNA-Seq with these
controls [31] as well as linearity between RNA-Seq and
arrays [32]. We concluded that the negative relationship
between compensation and expression levels was a bio-
logical phenomenon.
Gene regulation might explain compensation
responses of individual genes. For example, genes show-
ing anti-compensation could be auto-regulatory and the
loss of one copy might create a downward spiral due to
loss of positive feedback. It follows that gene-specific
dosage compensation mediated by network interactions
should change as the structure of the network and asso-
ciated gene expression levels changed.
At the genome-wide level, sex differences in gene
expression were much more prevalent compared to the
effect caused by gene dose. Expression profiles showed
clear signatures of sex, and with the exception of Df
(2L)ED793/+ females, only very subtle expression dif-
ferences between lines within a sex (Figure 4a). The
pervasive effect of sex on gene expression should drive
the expression of one-dose genes to differing degrees
in the sexes. If genes with sex-biased expression show
different dosage compensation responses in females
and males, this would suggest that compensation was
network-dependent. To test this, we grouped genes
detectably expressed in both sexes into those with
female-, male-, or non-biased expression according to
a database of sex-biased gene expression [33]. One-
dose genes with female- or male-biased expression
(Figure 4b,c), showed much less consistent compensa-
tion between the sexes (r = 0.47 and 0.49, respectively)
compared to one-dose genes with non-biased expres-
sion (r = 0.75; Figure 4d), suggesting that network
context modulated compensation.
Expression of two-dose genes in Df/+ flies
Dosage effects and compensation by interactions within
networks require perturbation detection by the network,
which is then followed by feedback correction. In other
words, perturbation propagation into the wild-type dose
regions of the genome must precede compensation in
temporal sequence. While all our observations were on
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steady-state conditions, we asked if there were any sig-
natures of propagation in our datasets. Propagation
would result in differentially expressed genes outside of
the one-dose regions (two-dose genes, which includes
dosage-compensated × chromosome genes in the case
of males). Changes in two-dose gene expression were
extensive. Collectively, the Dfs we used altered the dose
of approximately 5% of Drosophila genes, but we
observed change in approximately 80% of Drosophila
genes in at least one Df/+ line relative to the parental
w1118 line. Such changes did not appear to be a general-
ized response to aneuploid stress, as very few two-dose
genes changed expression in all lines (nine in females,
seven in males, and none in both sexes). Additionally,
we observed no obvious ontology commonalities among
these genes. The absence of a strong stress response
Figure 3 Dosage compensation and expression level. (a-d) Ratio intensity (MA) scatterplots showing two-dose array expression values
plotted against fold difference in expression in one-dose versus two-dose. (a,b) The full 21-line data set from microarray experiments. Expected
values for full compensation (thin solid lines) and non-compensation (thin dashed lines) are shown. (c,d) Data from three lines tested by Illumina
RNA-Seq (yellow), SOLiD RNA-Seq (green) or Nimblegen array (black). Trend-lines for each plot are shown (bold lines). (e) Measurements on
External RNA Control Consortium (ERCC) control RNAs of known relative abundance (for example, spike-ins) with 1:1 and 1.5:1 ratios across the
two mixtures (mix 1 and mix 2). (c,d,e) Expected values for 1:1 (solid line) and the two 1:1.5 ratios (dotted lines) are shown.
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[13] in our flies may be due to the rather limited num-
ber of genes with reduced gene dose in many of the
deficiencies.
Our data showed that Df/+ genes compensated in the
absence of a common two-dose genome response. The
absence of evidence for induced expression (or repres-
sion) of a characteristic set of genes in the Df/+ flies is
sensu stricto evidence against a general aneuploid
response. We therefore used a reference composed of
median expression values for all Df/+ lines to more
cleanly examine two-dose gene expression change
caused by particular Df/+ genotypes. Subtle expression
change among two-dose genes was extensive and het-
erogeneous among the 21 lines (mean = 524.6 genes in
females and 542.5 in males, or about 20 two-dose genes
per one-dose gene; Additional file 4).
If changes in two-dose genome expression were due to
regulatory interactions, then there should be a non-
random set of changes that can be traced back to a cau-
sal one-dose gene. We tested for such gene expression
network coherence and perturbation propagation by
projecting our data onto the first sex-specific gene-
expression network models for Drosophila. We con-
structed these networks from the expression data gener-
ated here, using mutual information, a quantity
measuring the dependency between two variables, which
has an important advantage over simple correlation
methods, as it incorporates complicated nonlinear
dependent relationships that better capture the relation-
ships between complex genotypes and phenotypes [34]
and relatedness in expression profiles [35]. Briefly, like
many known biological networks, both our female and
male networks (Additional files 5 and 6) exhibited scale-
free properties; however, the power law exponents were
different between sexes (-1.06 for female versus -1.35
for male), indicating that the overall structure of the
Figure 4 Dosage compensation in the context of sex. (a) Heat map showing overall correlations between each sample. The first three
columns and rows in both the case of females and males represent expression profiles from the non-deleted w1118 parental strain biological
triplicates. The triplicates of the Df(2L)ED793/+ females are indicated (’E’s). (b-d) Scatterplots of compensation ratios for the same genes when
measured in females versus males. Wt, wild type.
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networks differed between females and males (Table 2).
Gene connectivity was higher in the female-specific net-
work (P < 0.01 by degree-preserving edge shuffling; this
method exchanges endpoints of edges under the restric-
tion that the edges do not already exist in the network),
and the subnetwork of genes with female-biased expres-
sion had significantly larger clustering coefficients than
the subnetwork of genes with male-biased expression.
Similarly, in the male network, genes with male-biased
expression showed higher clustering than genes with
female-biased expression. These differences in network
structure were due only in part to sex-biased expression,
as even among genes with non-sex-biased expression
the clustering coefficients differed significantly in the
female and male networks. Why the female and male
mutual information models differ to this degree is not
entirely clear, but for our purposes here, these two mod-
els provide distinct and independent frameworks for
examining the propagation of dosage effects.
After projecting the expression data onto the net-
work models we observed patterns of extensive con-
nection between one-dose and two-dose genes.
However, due to the large number of possible paths
through these connections, we explored the relation-
ship between one-dose genes and the local network, by
examining expression changes for the unique first-
degree two-dose neighbors of every one-dose gene in
the sex-specific mutual information networks. Addi-
tionally, we also used a pre-existing network model
that combines genetic interactions from Drosophila
forward genetics, yeast two-hybrid data, and microar-
ray expression datasets [36]. For all three networks, we
calculated the probability of expression change in
those unique first-degree neighbors among the differ-
ent compensation categories (over-, partially, fully,
non-, and anti-compensated). We found that one-dose
genes with anti-compensated expression had two-dose
first-degree neighbors with the highest probability of
expression change (Figure 5a,b) irrespective of network
model or sex. The propensity for first-degree neighbor
change in expression networks centered on one-dose
genes indicates that dosage effects are mediated, at
least in part, by network interactions.
Outside of the anti-compensated class, the behavior of
first-degree two-dose neighbors differed by sex and
network. In females, there was significant stabilization of
first-degree neighbor expression surrounding genes with
partial or full compensation. These results are consistent
with perturbation spreading, followed by robust resis-
tance to expression change among neighbors of partially
and fully compensated genes. In males, however, expres-
sion of first-degree neighbors approached the global
average, with the notable exception of the anti-compen-
sation class. The reason for this sex-difference is
unclear.
Simple network interactions among first-degree neigh-
bors centered on one-dose genes suggest that a given
one-dose gene directly regulates some neighboring two-
dose genes. Given that the one-dose gene is the cause of
the perturbation, then we can determine whether propa-
gation is due to positive or negative interactions in the
gene pair. Globally, two-dose genes showed little bias in
the direction of expression difference (Figure 5c,d). We
therefore looked for skewing in the direction of two-
dose gene responses among first-degree neighbors of
one-dose genes. We observed a strong preference (P <
0.01, Chi-square test) for lower expression in the first-
degree neighbors of anti- or non-compensated genes
and for increased expression in the first-degree neigh-
bors of partially, fully, and over-compensated genes (Fig-
ure 5c,d). An example of such a first-degree neighbor
map centered on a one-dose gene is shown in Figure 5e.
The non-random nature of first-degree neighbor change
directionality strongly suggests that there was informa-
tion flow between the one-dose genes and the surround-
ing two-dose genes. These relationships were dominated
by sympathetic responses, suggesting positive regulation.
There was changed expression of two-dose genes
beyond what we could unambiguously trace through the
networks. We asked if these changes in expression were
coherent by focusing on genes encoding members of
protein complexes. The Drosophila Protein interaction
Map (DPiM) is a Drosophila protein-protein interaction
model for protein complexes based on co-affinity purifi-
cation followed by mass spectrometry [37]. We exam-
ined expression changes in the Df/+ lines for two-copy
genes encoding members of 23 high-confidence multi-
subunit complex models from DPiM to determine if
changed expression in one member was associated with
an enriched chance for expression change in another
Table 2 Topological statistics for female and male mutual information networks
Female network Male network
Expression bias Female Male None All Female Male None All
Number of nodes 3,456 789 1381 5,933 2,922 2,639 1,978 8,005
Clustering coefficient 0.44 0.30 0.36 0.44 0.12 0.31 0.19 0.23
Average neighbors 76.66 8.29 18.45 89.82 7.73 53.78 9.13 43.72
Density 0.022 0.01 0.013 0.015 0.003 0.02 0.005 0.005
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Figure 5 Propagation of expression changes into two-dose genes. (a,b) The probability of two-dose first-degree neighbors of one-dose
genes changing expression by compensation response classification of the one-dose gene in females and males. (c,d) The proportions of two-
dose first-degree genes with a positive direction of expression responses. Global averages for all two-dose genes are indicated (dotted lines).
Significant differences from global values (P < 0.01, Chi-square test) are shown (asterisks). (e) Two-dose first-degree neighbors (elliptical nodes) of
the anti-compensated gene atilla (rectangular node). Gene names are indicated for each node.
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gene encoding a complex member (Figure 6). Of the 966
cells in the matrix (23 complexes × 21 lines), we
observed significant co-expression change in 37 cases (P
< 0.01, hypergeometric test). These data suggest that
expression changes in the one-dose region of the gen-
ome preferentially affect two-dose genes encoding mem-
bers of the same protein complexes. This is strong
evidence that one-copy genes result in coherent expres-
sion perturbation in the two-dose genome beyond the
first-degree neighbors.
Discussion
The relationship between DNA dose and gene expres-
sion in Drosophila is poorly understood, but gene pro-
duct balance is clearly important [7,38]. For example,
assembly of multi-subunit complexes such as ribosomes
is highly sensitive to changes in the dose of constituent
proteins. Additive effects of massive gene dose devia-
tions are incompatible with life in Drosophila and, given
a sensitive assay, the gene doses of single modifiers have
pronounced phenotypic effects. It follows that there
should be a response to gene dose beyond the genes
with reduced dose and some of those changes will
involve feedback onto the genes with altered dose. Stu-
dies of Drosophila structural variants have shown partial
dosage compensation of autosomal genes as measured
as a population of genes with altered dose [8-10,14].
This partial compensation could be the result of uni-
form compensation of all genes, or heterogeneous
responses with a characteristic mean.
Network properties contribute to dosage compensation
Briefly, we have shown that one-dose genes show indivi-
dual expression responses to reduction in dose. While
Figure 6 Expression changes for two-dose genes encoding members of protein complexes. (a) Heat map showing the joint probability of
change in expression and uniformity in direction of change for DPiM protein complex models (rows) in each Df/+ line (columns) in females
(left) and males (right). The double deletion Df(2L)ED478, Df(2L)Hsp60c is indicated (asterisk). The inverse P (hypergeometric test) log scale is
shown. (b) Two examples showing the expression of two-dose genes encoding two different complexes in the indicated Df/+ line and sex.
Increased (red), decreased (green) and no expression difference (open) are indicated. Gene names are indicated for each node.
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we cannot rule out some contribution of a stereotypic
aneuploid response resulting in partial compensation,
the overall response is highly heterogeneous. In humans,
it also appears that individual genes can show very good
(rare), or negligible (common), compensation, suggesting
that gene-by-gene compensation is not restricted to
Drosophila [39]. Inverse effects, where gene expression
is anti-correlated with gene dose, are well-known in
maize [40], and we see rare over-compensation resulting
in higher expression when dose is reduced in Droso-
phila. We suggest that the compensation of one-dose
genes occurs in the context of the surrounding gene
expression network. Similar effects occur in mice, where
some one-dose genes show compensation during speci-
fic temporal windows, strongly suggesting feedback reg-
ulation [41]. We also demonstrate that perturbation
coherently propagates from one-dose genes into the net-
work. This indicates that autosomal dosage compensa-
tion and the consequences of the absence of dosage
compensation are, at least in part, network properties.
The differences in compensation in these diverse sys-
tems may be due to the relative portions of compensa-
tion gene classes, and/or network architecture, rather
than a gross difference in gene behavior between
organisms.
We showed that the gene-by-gene response to dose
depends on two related factors; gene expression level
and network context. Compensation is poorer for highly
expressed genes, and indeed the relationship between
compensation and expression shows some hints of con-
verging on non-compensation at high expression levels.
Our results are consistent with the observation that tis-
sue-specifically expressed genes were better compen-
sated in Drosophila compared to ubiquitously expressed
genes [8], as non-ubiquitously expressed genes show
lower expression in whole animal samples. Additionally,
our data at high expression levels is consistent with the
response in yeast, where highly expressed genes show
no dosage compensation at the protein level while a
minority are perfectly compensated [42]. Our results dif-
fer from another recent report that highly expressed
Drosophila genes were better compensated [14]. Because
of the highly heterogeneous gene-specific response to
dose, it is quite possible that these differences in conclu-
sions are due to the particular regions of the genome
examined. While we do not understand why compensa-
tion depends on steady-state expression level, it is possi-
ble that better compensation of poorly expressed genes
is due to robust control of expression where low abun-
dance increases deviations due to stochastic noise. As
an extreme example, a transcript present at, or below,
one copy per cell must result in wild swings in fold rela-
tionships to other transcripts, and might be an excellent
candidate for compensation. Poor compensation of
highly expressed genes may be due to ‘speed limits’
imposed by maximal rates of transcription for a particu-
lar arrangement of regulatory sequences at that locus.
Our study demonstrates that there are coherent pat-
terns of expression change in potentially co-regulated
complexes and immediate neighbors of one-dose genes.
It seems likely that both kinetics and active regulation
are components of network mediated dosage compensa-
tion and propagation. Transcription is an enzymatic
process, and changes in enzyme concentration in path-
ways are buffered by substrate and reactant concentra-
tions that depend on other enzymes in the pathway
[20], such that flux varies between no change and
change of the same magnitude as the dose change.
However, buffering does not explain the anti- and over-
compensation we observed, suggesting that active regu-
lation via feedback is also a component of dosage com-
pensation. Buffering and feedback are not mutually
exclusive. For example, the yeast galactose network
(involving GAL2, GAL3, GAL4 and GAL80) is robust to
gene dose alterations through a simple two-component
system with at least one inhibitor and one activator reg-
ulating the pathway. However, activator-inhibitor inter-
actions and stoichiometry in the galactose network have
profound effects on the robustness of the network [43].
Our work suggests that the anti-compensated genes
might result in the most damage to the rest of the gene
expression network, or minimally, that the damage is
more easily traced into the expression network in our
models. These dose effects indicate that anti-compen-
sated genes are weakly haploinsufficient and are good
candidates for pathological variants. At least in females,
the over-compensated genes also appear to result in
clear propagation of perturbation and are likely to be
damaging to the expression network. Another female-
restricted response suggests that genes with partial or
full dosage compensation increase the robustness of the
local expression network centered on those genes. That
males show different propagation patterns could be due
to inherent differences between females and males or
differences in network model quality. Despite these dif-
ferences, in both female and males we observed sympa-
thetic changes in expression of first-degree neighbors of
one-dose genes. These data suggest that most causal
relationships identified are positive, despite the fact that
mutual information networks identify both correlated
and anti-correlated relationships.
What about sex chromosomes?
While we do not examine × chromosome dosage com-
pensation in this manuscript, our findings do have some
implications for some of the models for sex chromo-
some dosage compensation. The majority of studies sug-
gest that the male × chromosome is upregulated to
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achieve compensation in Drosophila [15]. However, it
has also been suggested that interaction between the
autosomes and the × chromosome contributes to ×
chromosome dosage compensation by lowering autoso-
mal expression in males [38]. The relationship between
the non-compensated genes and first-degree neighbor
expression we observe here is sympathetic. If this is also
true for × chromosome genes, then one effect of non-
compensation of X-linked genes would be to lower
expression of first degree neighbors encoded on auto-
somes. Therefore, × chromosome-autosome interactions
might act to partially balance gene expression by lower-
ing autosomal expression. While we have previously
reported that models calling for up-regulation of the ×
in Drosophila males explains more of dosage compensa-
tion than possible network interactions with the auto-
somes [10], it is quite possible that such interactions
exist. It is perhaps even more likely that these interac-
tions existed and shaped dosage responses during the
evolution of the × and Y chromosomes from an ances-
tral autosome pair [44]. As genes are lost from neo-Y
chromosomes there is a gradual crisis that is not effec-
tively controlled by chromosome-wide mechanisms until
Y-chromosome gene loss is extreme (evolutionarily pre-
mature dosage compensation would make males func-
tionally triploid for genes present on the × and Y). Sex
chromosome-wide mechanisms that have evolved also
create imbalances. Network interactions between the ×
and autosomes could also contribute to the equilibration
of × and autosome expression in XY male mammals and
in XX females following × inactivation [18]. Similarly,
network effects might also help explain dosage compen-
sation in the absence of MSL in the early Drosophila
XY male soma and mitotic germline [9,17,18].
Our results also point out the complications of char-
acterizing sex chromosome dosage compensation in the
absence of a baseline value for autosomal compensation.
For example, in light of our findings, it is unclear if par-
tial sex chromosome compensation in birds [45] is due
to a generic response to monosomy or a chromosome-
specific compensation mechanism with limited efficacy.
On the other hand, possible sex chromosome heteroge-
neity in baseline compensation in the absence of a chro-
mosome-wide mechanism also cautions against using
global expression values to make broad statements
about sex chromosome dosage compensation. Specifi-
cally, it has been proposed that intermediate × chromo-
some compensation in the wild-type Drosophila male
germline is due to a fixed fold effect of failed × chromo-
some dosage compensation [46], rather than complica-
tions due to measuring expression in mixes of cells
showing dosage compensation, sex-biased gene content,
and the precocious × chromosome inactivation that
occurs in male germ cells ranging from Caenorhabditis
elegans to human [18,47]. The clearest conclusion for
the study of sex chromosome compensation is that one
should not assume that the two-fold difference in gene
dose is easily corrected by a fixed-fold dosage compen-
sation system, as the baseline expression for ‘non-com-
pensated’ sex chromosome genes may well differ among
sex-linked genes. The study of sex chromosome dosage
compensation will need to be coupled with studies of
dosage compensation elsewhere in the genome.
Building better network models
Our network modeling shows a common thematic con-
nection between one-dose genes and the rest of the gen-
ome, but these models are far from complete and differ,
for example, in the specific genes we called first-degree
neighbors. Systematic subtle perturbation using gene
dose is a good tool for generating better network mod-
els. Specifically, since we can trace propagating changes
in engineered Drosophila where the causal dose change
is known, we can move beyond connectivity to informa-
tion flow within current network models and use these
data iteratively to build better models. For example, the
expression values for a given gene pair connected by an
edge are the result of one gene regulating the other
(directly or indirectly) or both genes being co-regulated
by a common first-degree neighbor. In a positive inter-
action, the predicted response to an instantaneous gene
dose reduction is reduced expression of directly regu-
lated neighbors; however, if a third gene responds to
one-dose expression by increasing the expression of this
co-regulated pair, then the first degree neighbor of the
one-dose gene should be over-expressed. Indeed, we
observed that partially compensated genes were
enriched for over-expressed first-degree neighbors in
both sexes. A larger data set, where each node in a sub-
network is one-dose in one experiment and two-dose in
the others, should allow us to unambiguously determine
if relationships are directional and, if so, whether the
effect is positive or negative. With better models, we
should be able to predict information flow, and perhaps
dose-dependent genetic interactions resulting in oligo-
genic phenotypes. Finally, if we can establish a basic
understanding of gene dose responses in Drosophila, we
may be able to apply basic rules to copy number varia-
tions associated with human disease, which also appear
to be mediated by network responses [48].
Materials and methods
Flies and samples
We obtained flies from the Drosophila stock center
(Bloomington, IN, USA). We crossed DrosDel males to
virgin w1118 females to remove balancer chromosomes.
We determined that the line initially labeled Df(2L)
ED748 had the breakpoints reported for Df(2L)ED478,
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and changed the labeling in this report accordingly. This
line also carried an additional 2L deletion (Figure 1).
Flies were grown under constant temperature and
humidity (25°C; 60% relative humidity) on San Diego
Stock Center cornmeal media [49]. We pooled 50 to 60
sexed adults (5 days post-eclosion) for RNA extraction
for each of 3 to 4 replicate preparations. Total RNA was
extracted using TRIzol® (Invitrogen, Carlsbad, CA,
USA) and poly A+ mRNA was enriched using Oligotex
(Qiagen, Valencia, CA, USA) following the manufac-
turer’s instructions. mRNA quality was scored by the
presence of tight rRNA bands in Bioanalyzer profiles
(Agilent, Santa Clara, CA, USA). We extracted DNA
using the LiCl method [50] and quantified on a Nano-
drop (Thermo Fisher, Wilmington, DE, USA).
Arrays and sequencing
All array and sequence data are available from the Gene
Expression Omnibus (GEO) [51]. See GEO GPL8593 for
array platform details and GEO GSE31407 for complete
methods and supplemental information. We used a 12-
plex 60-mer probe microarray, 080523_D_melanogas-
ter_5.5_expr (Roche Nimblegen, Madison, WI, USA),
and performed experiments in at least biological tripli-
cates as described [10] in a chamber with air passed
through NoZone ozone scrubbers (SciGene, Sunnyvale,
CA, USA). All array data were in log2 scale. We normal-
ized all microarray data triplicates with rank correlation
≥0.8 using Robust Multi-Chip Averaging [52] to produce
a gene level metric of expression. Two sample hybridiza-
tions failed to meet this threshold and were not further
considered. We then set the threshold of detected
expression at 2 SD above mean hybridization intensity
to control probes. We demanded that a given gene
show within-sex expression above this threshold in all
tested lines. We used two types of references in the
manuscript. When testing for a global effect of aneu-
ploidy, we used median expression of the w1118 line as a
denominator. When we were testing for the effect of
particular deficiencies, expression ratios were compari-
sons to a composite reference built from the median
expression values from all experiments. Expression dif-
ferences were called by false discovery rate-corrected (P
< 0.05) moderated t-tests [53,54].
For RNA-Seq, 100 to 200 ng of poly-A+ mRNA from
samples along with external spike-in control libraries
were prepared for sequencing on a GAII (Illumina, San
Diego, CA, USA) or SOLiD 4 (Life Technologies,
Carlsbad, CA, USA). We used 8 [55] external control
RNAs for Illumina RNA-Seq and 96 [31] ERCC exter-
nal control RNAs for SOLiD RNA-Seq. For the ERCC
controls mix 1:mix 2 ratios contain three subsets of 32
RNAs at 1:1, 1.5:1, and 1:1.5, with a dynamic concen-
tration range of 220. Mix 1 was added to wild-type
mRNA and mix 2 was added to Df/+ mRNAs. For Illu-
mina runs, we used 36 bp reads that passed default
parameters, Chastity ≥0.6 (Illumina). For SOLiD runs,
we used only the forward read and trimmed these
reads from 50 to 36 bp based on analysis of read qual-
ity and to make data comparable to Illumina data. For
DNA-Seq, 5 μg of DNA was prepared as described
[10] and sequenced on a GAII or HiSeq 2000 (Illu-
mina) as outlined for RNA-Seq.
We used the dm3 Drosophila melanogaster sequence
build [56] from the UCSC Genome Browser [57] as a
reference (excluding Uextra) for alignment using Bowtie
v.0.12.7 settings -v 2 -m 1 [58] and FlyBase r5.29 for
annotations [59]. We quantified expression using HTSeq
union mode [60], and used the unique mapping reads to
calculate reads per kb per million mapped (RPKM) as
the normalized metric of gene expression. We identified
the novel Df breakpoint with rSW-Seq [61] and deter-
mined fold-difference for aneuploid segments with sam-
tools [62], which we expressed as reads per million
(RPM). All but the smallest 5 kb deletion was detected
using this method. We did not attempt to measure sin-
gle nucleotide polymorphisms. We visualized expression
data with Bioconductor tools [63] or MatLab (Math-
works, Natick, MA, USA), and DNA-Seq coverage with
Bedtools [64] and the UCSC Browser.
Network analysis
We used a two-step procedure to classify the expression
of one-dose genes into five groups: anti-compensated,
non-compensated, fully compensated, partially compen-
sated, and over-compensated. First, using a moderated
t-test, we tested the null hypothesis that the expression
of one-copy genes was reduced by half compared to the
DrosDel reference values for each gene. We rejected the
null hypothesis for all genes with P < 0.05 (limma pack-
age from Bioconductor [63] with false discovery rate by
Benjamini-Hochberg correction [54]). The genes for
which the null hypothesis was not rejected were classi-
fied as non-compensated. We classified genes for which
the null hypothesis was rejected and expression was
lower than the expected two-fold reduction as anti-com-
pensated. Next, the genes for which the null hypothesis
was rejected and the expression was higher than the
expected two-fold reduction (199 genes in females and
242 gene in males) were stratified into compensation
levels - fully compensated, partially compensated and
over-compensated - using cutoff values defined as fol-
lows. To set appropriate cutoff values, we first estimated
the distribution of log fold change in this group by sam-
pling 1,000 times with repetition, and subsequently
computed normal distribution based cutoff for the quin-
tiles 2.5% and 97.5%. These cutoffs where then adjusted
by subtracting the sampled population mean, thus
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centering the confidence interval at ‘no change’ relative
to the reference. Finally, the genes with mean log-fold
expression change between the cutoffs were classified as
fully compensated, the ones above the upper cutoff as
over-compensated and ones below the lower cutoff as
partially compensated.
We used our gene expression data (subtracted mean
expression for each gene across lines and replicates/SD)
as a variable and estimated mutual information (MI) for
all possible pairs of genes by a kernel method [65] to con-
struct the sex-specific models (kernel width = 0.3; edges
with MI P < 0.005). Unlike simple correlation, MI tests
non-linear relationships and does not require that the
distribution of variables is normal. In addition, MI net-
works have been shown to perform well on simulated
data and to be more resilient to estimation errors [66].
We used other networks as described by the creators
[36,37]. Twenty-three protein complexes enriched for
ontology terms (P < 0.005) and having ten or more mem-
bers were selected directly from the DPiM network with-
out further processing [36,37], and we used the
hypergeometric test for significance of expression change.
We visualized networks in Cytoscape v.2.8 and used
the Network Analysis and Random Network plug-ins to
fit power-law models, generate randomized networks
and generate descriptive statistics for the female and
male networks [67,68]. We used the one-versus-every-
one approach [69] to identify significantly changed 1st
degree neighbor expression change, and we calculated
the global probability of changed expression from all
nodes in each network and compared to observed by
Chi-square test. Probabilities are indicated in the main
text. We performed network statistics and analysis in
MatLab (Mathworks).
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